Literature DB >> 33636012

Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis.

Binu V John1, Gabriella Aitcheson2, Kaley B Schwartz1, Nidah S Khakoo2, Bassam Dahman3, Yangyang Deng3, David Goldberg4, Paul Martin4, Tamar H Taddei5,6, Cynthia Levy4, David E Kaplan7,8.   

Abstract

BACKGROUND AND AIMS: The impact of sex on the postcirrhosis progression of primary biliary cholangitis (PBC) has not been well defined. Prior studies have suggested that men have worse outcomes but present at more advanced stages of fibrosis than women. This observation, however, has been limited by small numbers of men and even fewer patients with cirrhosis. APPROACH AND
RESULTS: We investigated the association of sex with the development of all-cause and liver-related mortality or transplantation, decompensation, and hepatocellular carcinoma (HCC), using competing-risk time-updating Cox proportional hazards models in a large cohort of predominantly male patients with PBC cirrhosis assembled from the Veterans Health Administration. In a cohort of 532 participants (418 male) with PBC-related cirrhosis with a total follow-up of 3,231.6 person-years (PY) from diagnosis of compensated cirrhosis, male participants had a higher unadjusted rates of death or transplantation (8.5 vs. 3.8 per 100 PY; P < 0.0001), liver-related death or transplantation (5.5 vs. 2.7 per 100 PY; P < 0.0001), decompensation (5.5 vs. 4.0 per 100 PY; P = 0.002), and HCC (0.9 vs. 0.3 per 100 PY; P < 0.0001). After adjusting for confounders, male sex was associated with a higher risk of death or transplantation (adjusted hazard ratio, 1.80; 95% CI, 1.01-3.19; P = 0.046), and liver-related death or transplantation (subhazard ratio, 2.17; 95% CI, 1.15-4.08; P = 0.02). A sensitivity analysis that defined ursodeoxycholic acid response as normalization of alkaline phosphatase and total bilirubin revealed similar findings.
CONCLUSIONS: In patients with PBC and well-compensated cirrhosis, male sex is associated with a higher risk of both death and liver-related death or transplantation.
© 2021 by the American Association for the Study of Liver Diseases. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Mesh:

Year:  2021        PMID: 33636012     DOI: 10.1002/hep.31776

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.

Authors:  Binu V John; Bassam Dahman; Yangyang Deng; Nidah S Khakoo; Tamar H Taddei; David E Kaplan; Cynthia Levy
Journal:  Liver Int       Date:  2021-10-12       Impact factor: 5.828

2.  Update on the Evaluation and Management of Portal Hypertension.

Authors:  Gabriella Aitcheson; Carensa Cezar; Irene John; Binu V John
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

3.  REPLY.

Authors:  Binu V John; Yangyang Deng; Paul Martin; Cynthia Levy; Tamar H Taddei; David E Kaplan; Bassam Dahman
Journal:  Hepatology       Date:  2021-08-15       Impact factor: 17.298

4.  REPLY.

Authors:  Binu V John; Bassam Dahman; Tamar H Taddei; Cynthia Levy; David E Kaplan
Journal:  Hepatology       Date:  2021-07-20       Impact factor: 17.298

5.  Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort.

Authors:  Nadim Mahmud; Sara Chapin; David S Goldberg; K Rajender Reddy; Tamar H Taddei; David E Kaplan
Journal:  J Hepatol       Date:  2022-01-21       Impact factor: 30.083

6.  A Novel Nomogram for Predicting Postoperative Liver Failure After Major Hepatectomy for Hepatocellular Carcinoma.

Authors:  Zhengqing Lei; Nuo Cheng; Anfeng Si; Pinghua Yang; Guangmeng Guo; Weihu Ma; Qiushi Yu; Xuan Wang; Zhangjun Cheng
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

7.  Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.

Authors:  Binu V John; Yangyang Deng; Kaley B Schwartz; Tamar H Taddei; David E Kaplan; Paul Martin; Hann-Hsiang Chao; Bassam Dahman
Journal:  Hepatology       Date:  2022-02-22       Impact factor: 17.298

Review 8.  Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice.

Authors:  Federica Invernizzi; Marta Cilla; Silvia Trapani; Maria Guarino; Valentina Cossiga; Martina Gambato; Maria Cristina Morelli; Filomena Morisco; Patrizia Burra; Annarosa Floreani
Journal:  J Pers Med       Date:  2022-06-02

9.  Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.

Authors:  Binu V John; Raphaella D Ferreira; Akash Doshi; David E Kaplan; Tamar H Taddei; Seth A Spector; Elizabeth Paulus; Yangyang Deng; Dustin Bastaich; Bassam Dahman
Journal:  J Hepatol       Date:  2022-09-28       Impact factor: 30.083

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.